| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.051 | 28.112 | 30.079 | 31.568 | 34.108 | 36.287 | 48.818 | 45.286 | 57.525 | 57.939 |
| Total Income - EUR | 27.052 | 30.135 | 30.079 | 31.568 | 34.635 | 36.288 | 48.821 | 45.972 | 57.530 | 57.941 |
| Total Expenses - EUR | 10.934 | 12.932 | 14.821 | 13.834 | 17.506 | 16.250 | 19.698 | 23.050 | 25.440 | 30.504 |
| Gross Profit/Loss - EUR | 16.118 | 17.203 | 15.258 | 17.734 | 17.128 | 20.038 | 29.124 | 22.923 | 32.090 | 27.437 |
| Net Profit/Loss - EUR | 15.306 | 16.360 | 14.768 | 16.851 | 16.195 | 19.091 | 27.971 | 21.976 | 31.603 | 26.858 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bio-Risc Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 508 | 130 | 7.023 | 12.599 | 12.456 | 7.596 | 20.711 | 14.043 | 11.004 | 8.204 |
| Current Assets | 22.374 | 23.068 | 17.506 | 12.385 | 13.229 | 22.446 | 18.272 | 19.972 | 33.004 | 35.850 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 20.115 | 15.621 | 12.814 | 7.769 | 7.998 | 4.960 | 4.569 | 1.582 | 2.170 | 4.881 |
| Cash | 2.259 | 7.447 | 4.692 | 4.616 | 5.231 | 17.486 | 13.703 | 18.389 | 30.834 | 30.969 |
| Shareholders Funds | 20.475 | 22.374 | 23.744 | 24.371 | 25.342 | 29.481 | 38.604 | 33.366 | 43.087 | 43.098 |
| Social Capital | 4.499 | 4.454 | 4.378 | 4.298 | 4.215 | 4.135 | 4.043 | 4.056 | 4.043 | 4.021 |
| Debts | 2.407 | 824 | 784 | 613 | 343 | 561 | 378 | 649 | 921 | 956 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Bio-Risc Srl